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A B S T R A C T
()-Cubebin is a lignan extracted from the seeds of the pepper Piper cubeba, a commonly eaten spice with
beneﬁcial properties, including trypanocidal, anti-inﬂammatory, analgesic, anti-proliferative and
leishmanicidal activities. Because of its therapeutic potential, we investigated the effects of ()-
cubebin on the cytotoxicity, cell proliferation kinetics, mutagenicity and expression of p38 MAP kinase
and glutathione S-transferase a2 (GSTa2) using real-time RT-PCR in Rattus norvegicus hepatoma cells. We
found that 280 mM ()-cubebin was cytotoxic after 24, 48 and 72 h of exposure, but not mutagenic at
0.28 mM, 2.8 mM and 28 mM after 26 h. Similarly, exposure to 0.28 mM, 2.8 mM and 28 mM ()-cubebin
for 24, 48, 72 and 96 h did not alter the cell proliferation kinetics. Cells exposed to 28 mM ()-cubebin for
24 h did not exhibit changes in p38 MAP kinase and GSTa2 expression, indicating that cellular changes
were not induced by extracellular stimuli and that ()-cubebin is likely not metabolized via this
pathway. Our results suggest that high levels of ()-cubebin should be consumed with caution due to the
cytotoxic effect observed at the highest concentration. However, at lower concentrations, no cytotoxic,
mutagenic or proliferative effects were observed, providing further evidence of the safety of consuming
()-cubebin.
 2013 Elsevier Inc. 
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The pepper Piper cubeba, known as the cubeb pepper, tailed
pepper or Java pepper, is a popular spice consumed throughout
Europe as well as in many other countries, including Arabia, India,
Indonesia and Morocco (Junqueira et al., 2007). This pepper has
been used since the Middle Ages as both a spice and in the practice
of traditional medicine for the treatment of various diseases. The
genus Piper includes more than 1000 species of plants, which grow
as weeds, brush or, less frequently, as standing or sustained trees
(Junqueira et al., 2007), and they are primarily found in Asia and
the New World (Nunes et al., 2007).
Recent studies have shown that the lignan dibenzylbutyrolac-
tone ()-cubebin can be extracted from the seeds of P. cubeba. This
lignan has several beneﬁcial properties, including trypanocidal
(Bastos et al., 1999; de Souza et al., 2005), analgesic, anti-
inﬂammatory (Bastos et al., 2001), leishmanicidal (Bodiwala et al.,
2007) and anti-proliferative (Yam et al., 2008) activities. Lignans* Corresponding author at: Departamento de Biologia Geral – CCB, Universidade
Estadual de Londrina – Campus Universita´rio, Rodovia Celso Garcia Cid, Pr 445 Km
380, Campus Universita´rio, P.O. Box 6001, Londrina, Parana´, CEP: 86051-980, Brazil.
Tel.: +55 43 3371 4977.
E-mail address: andressamn@yahoo.com.br (A.M. Niwa).
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Open access under the Elsevier OA license.(from the Latin lignum, meaning wood) are phytoestrogens found
in a wide variety of plants (Krajcˇova´ et al., 2009). They consist of
dimers formed via the oxidative coupling of cinnamyl alcohols
with each other or with cinnamic acids (Barbosa Filho, 2004).
Despite the substantial consumption of P. cubeba in various
countries, few studies have evaluated the risks associated with the
consumption of this species. Given the promising therapeutic
potential of this lignan, the objective of this study was to assess the
cytotoxicity, mutagenicity and cell proliferation kinetics in HTC cells
(a Rattus norvegicus hepatoma cell line) treated with ()-cubebin.
We also examined cells exposed to ()-cubebin to determine the
expression of p38 MAP kinase, which is involved in several cellular
functions, such as inﬂammation, cell growth, differentiation, cell
cycle regulation and cell death (Zarubin and Han, 2005), and of
glutathione S-transferase (GST), which is involved in the metabolism
of xenobiotics. Collectively, these experiments provide data that
contribute to the safe therapeutic usage of ()-cubebin.
2. Materials and methods
2.1. ()-Cubebin extraction and preparation
()-Cubebin was obtained from powdered seeds of P. cubeba
imported from India via maceration with 96% ethanol. Details
Table 1
Oligonucleotide primers used for real-time RT-PCR.
Gene Primer sequence Reference
GAPDH F: 50 ACAAGATGGTGAAGGTCGGTGTCA 30 Tso et al. (1985)
R: 50 AGCTTCCCATTCTCAGCCTTGACT 30
p38 F: 50 AAGTCATTAGCTTTGTGCCACCGC 30 In this studya
R: 50 AGTGGGATGGACAGAACAGAAGCA 30
GSTa2 F: 50 AGCCATGGCCAAGACTACCTTGTA 30 Pickett et al. (1986)
R: 50 AGAGGTCAGAAGGCTGGCATCAAA 30
a The sequence of the forward and reverse primers was designed using the IDT
software (http://www.idtdna.com/Scitools/Applications/Primerquest).
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et al. (2011). The ()-cubebin, which was estimated to have a
purity of 99% by HPLC and spectral data analyses, with a yield of
2.24 mg/g dry seed. The ()-cubebin was diluted in dimethyl
sulfoxide (DMSO) (Mallinckrodt Chemicals, USA). The concentra-
tion of DMSO did not exceed 0.25% of the culture medium.
2.2. Induction of DNA damage
Doxorubicin (18.4 mM; Adriblastina1, Pharmacia, Italy) was
dissolved in culture medium and used to induce DNA damage for
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) cytotoxicity and cell proliferation kinetics assays.
For the cytokinesis-block micronucleus assay, the mutagen
benzo[a]pyrene (Fluka, Switzerland), which indirectly induces
DNA damage, was used at a concentration of 79 mM and dissolved
in 0.8% DMSO.
The use of doxorubicin was based on preliminary studies from
our group just to select which the cytotoxic concentration. The use
of benzo[a]pyrene as positive control in micronucleus assay was
due to the use of HTC cells (from rat hepatoma) to verify their
functional metabolic activity. Benzo[a]pyrene is an indirect-acting
mutagen, i.e., must be metabolized by cells to cause DNA damage
(Verma et al., 2012), providing evidence that HTC cells during the
micronucleus assay were metabolically active.
2.3. HTC cells
A R. norvegicus hepatoma cell line (HTC cells) was acquired from
the Rio de Janeiro Cell Bank (RJBC/UFRJ). HTC cells were grown at
37 8C in culture ﬂasks (25 cm2) containing a 1:1 mixture of
Dulbecco’s modiﬁed Eagle’s medium:nutrient mixture F-12 (Ham)
(Gibco, USA) and supplemented with an antibiotic–antimycotic
solution (Gibco, USA) and 10% fetal bovine serum (FBS) (Gibco, USA).
2.4. MTT cytotoxicity assay
The MTT assay (Invitrogen, Life Technologies, USA) was
performed according to the protocol described by Mosmann
(1983). Seeded 96-well culture plates (2.5  104 cells/well) were
incubated at 37 8C for 24 h. After this period, the following
treatments were administered for 24, 48 and 72 h: control (0.25%
DMSO); cytotoxicity inducer (18.4 mM doxorubicin); and ()-
cubebin at 0.028 mM, 0.28 mM, 2.8 mM, 28 mM and 280 mM. The
selection of concentrations used in MTT assay was based on in vivo
study of Maistro et al. (2011). DMSO at a concentration of 0.25%
was also administered to wells containing culture medium alone
(no cells) for use as a ‘‘blank’’ control. Three independent
experiments were performed, and each experiment included
twelve replicates.
2.5. Cell proliferation kinetics
Changes in cell proliferation were quantiﬁed in HTC cells
exposed to ()-cubebin for 24, 48, 72 and 96 h by manually
counting cells. Approximately 105 cells per culture tube (10 cm2)
were incubated under the following treatment conditions: control
(0.025% DMSO); DNA damage inducer (18.4 mM doxorubicin); and
()-cubebin (0.28 mM, 2.8 mM and 28 mM). The same treatment
conditions were tested in the remaining experiments. Three
independent repetitions were performed in each treatment.
2.6. Cell viability assay
Cell viability was measured by manually counting cells stained
with 0.2% trypan blue reagent (Gibco, USA) in a Neubauer chamber,according to Mauro et al. (2011). Every 24 h, 100 cells from each
treatment were counted over a total period of 96 h. The number of
viable versus nonviable cells was expressed as a percentage of the
total cell viability. Three independent experiments were per-
formed for each treatment condition.
2.7. Cytokinesis-block micronucleus assay and determination of the
nuclear division index
HTC cells (106) were grown in culture ﬂasks (25 cm2) for 24 h
prior to the administration of the different treatments. Binucleated
cells were obtained via incubation with 3 mg/mL cytochalasin-b
(Sigma–Aldrich, Germany) for 27 h. After this period, the cells were
harvested according to a previously published protocol (Martins de
Oliveira et al., 2002). The slides were analyzed according to criteria
determined by Fenech (2000). Three independent experiments
were performed.
The nuclear division index (NDI) was also determined from
these slides and veriﬁed according to Eastmond and Tucker (1989).
Three independent experiments were performed.
2.8. Real-time RT-PCR
To evaluate p38 MAP kinase and GSTa2 gene expression, 106 HTC
cells were grown in culture ﬂasks (25 cm2) for 24 h and then
exposed to 28 mM ()-cubebin for a period of 12 h. After this
period, the cells were trypsinized, and total RNA was extracted
using TRIzol LS (Invitrogen, Life Technologies, USA). The extracted
RNA was treated with 1 U of DNase I Ampliﬁcation Grade
(Invitrogen, Life Technologies, USA). The purity of the sample
was conﬁrmed using a spectrophotometer (Eppendorf Biophot-
ometer, Germany), and sample integrity was veriﬁed via electro-
phoresis on a 0.8% agarose gel.
cDNA was synthesized from 1 mg of total RNA in a reaction
containing 0.25 mM dNTPs (Invitrogen, Life Technologies, USA),
10 pM oligo-dT (Invitrogen, Life Technologies, USA), 4 U of
RNaseOUTTM Recombinant Ribonuclease Inhibitor (Invitrogen, Life
Technologies, USA) and 200 U of M-MLV reverse transcriptase
(Invitrogen, Life Technologies, USA) in a total reaction volume of
20 mL. cDNA synthesis was carried out in a thermocycler at 37 8C
for 50 min, followed by 70 8C for 15 min.
Real-time PCR was performed in a PTC 200 DNA Engine Cycler
thermocycler using the Chromo4 detection system (MJ Research
BIO-RAD). PCR ampliﬁcation of each sample was performed in a
total reaction volume of 20 mL, which included 2 mL of cDNA and
0.25 mM of each forward and reverse primer, to amplify partial
regions of the p38 MAP kinase and GSTa2 genes (Table 1). cDNA
ampliﬁcation was measured according to the ﬂuorescence emitted
by the SYBR Green ﬂuorophore (10 mL; contained in the Platinum
SYBR Green qPCR Supermix-UDG kit, Invitrogen, Life Technologies,
USA). The PCR cycling conditions were as follows: an initial
denaturation step at 50 8C for 2 min followed by 95 8C for 3 min
Fig. 1. Average absorbance observed in MTT cytotoxicity assay after 24, 48 and 72 h of incubation with ()-cubebin. Control, culture medium 0.5% DMSO; DXR, 18.4 mM
doxorubicin (DNA damage inducer). *Signiﬁcant difference compared with the control (p < 0.05).
A.M. Niwa et al. / Journal of Food Composition and Analysis 30 (2013) 1–5 3and 39 cycles of 95 8C for 20 s, 60 8C for 30 s and 72 8C for 20 s, with
a ﬁnal step at 95 8C for 10 s followed by 40 8C for 1 min. Melting
curve analysis was performed at the end of the reaction by
increasing the temperature from 50 8C to 95 8C in steps of 0.5 8C
every 5 s. Each PCR ampliﬁcation was performed in two biological
experiments and with three mechanical replicates. The data were
normalized to the glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) gene.
2.9. Statistical analysis
The data obtained from the MTT, cell proliferation kinetics and
micronucleus assays were assessed using analysis of variance
(ANOVA) followed by Dunnett’s test. Comparisons were performed
between the ()-cubebin treatments and the control group using
GraphPad Instat, where p < 0.05 was considered statistically
signiﬁcant.
The expression levels of p38 MAP Kinase and GSTa2 were
determined using a method previously published by Pfafﬂ (2001).
The statistical analyses were performed using REST-384 software
(Pfafﬂ et al., 2002).
3. Results
The absorbance readings for HTC cells exposed to 0.028, 0.28,
2.8 and 28 mM ()-cubebin for 24, 48 and 72 h were not
signiﬁcantly different from the control group, suggesting that
()-cubebin is not cytotoxic when administered at theseFig. 2. Growth curve of HTC cells exposed to ()-cubebin for 24, 48, 72 and 96 h.
Control, culture medium with 0.025% DMSO; DXR, 18.4 mM doxorubicin (DNA
damage inducer).concentrations. However, exposure to 280 mM ()-cubebin
resulted in a signiﬁcant difference from the control group,
suggesting that this substance is cytotoxic at high concentrations
(Fig. 1). We omitted the 280 mM ()-cubebin treatment condition
from further testing because cell death may skew the results of the
following experiments. Next, we evaluated whether the prolifera-
tion of HTC cells exposed to 0.28, 2.8 and 28 mM ()-cubebin was
altered after 24, 48, 72 and 96 h of exposure. At these three
concentrations of ()-cubebin, the cell proliferation kinetics of the
HTC cells were not altered at any of the time points examined, and
there were no signiﬁcant differences detected compared to the
control group (Fig. 2). We conﬁrmed that there was no cytotoxicity
at these concentrations using a cell viability assay, in which no
signiﬁcant difference was observed in the cells exposed to ()-
cubebin compared to the control group at any of the time points
examined (Fig. 3).
To determine whether ()-cubebin is able to induce DNA
damage, a cytokinesis-block micronucleus assay was performed.
No signiﬁcant difference was found in the number of micronuclei
detected in the groups exposed to ()-cubebin for 26 h compared
to the control group, demonstrating that ()-cubebin is not
mutagenic at concentrations of 0.28, 2.8 and 28 mM (Fig. 4). There
was also no signiﬁcant difference in the NDI compared to the
control group under these conditions (Fig. 4).
In the real-time PCR reactions we considered the average values
of efﬁciency 80%. Next, we assessed whether HTC cells exposed to
28 mM ()-cubebin for 24 h exhibited altered levels of p38 MAP
kinase and GSTa2 gene expression. p38 MAP kinase and GSTa2 areFig. 3. Percentage HTC cells viability after exposure to ()-cubebin for 24, 48 and
72 h. Control, culture medium with 0.025% DMSO; DXR, 18.4 mM doxorubicin (DNA
damage inducer).
Fig. 4. Mean and standard deviation of the number of micronuclei (MN) and NDI in
HTC cells exposed to ()-cubebin for 26 h. Control, culture medium with 0.04%
DMSO; B[a]p, 79 mM benzo[a]pyrene (DNA damage inducer); MN, micronucleus;
NDI, nuclear division index. *Signiﬁcant difference compared with the control
(p < 0.05).
Fig. 5. Evaluation of the relative expression levels of p38 MAP kinase and GSTa2 by
real-time RT-PCR in HTC cells exposed to 28 mM ()-cubebin for 12 h. The data
were normalized to GPDH. No signiﬁcant difference was found in gene expression
levels according to the REST-384 software (Pfafﬂ et al., 2002). The comparison was
performed with the control group.
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respectively. The analysis of their expression could provide insight
into the cellular alterations resulting from exposure to ()-
cubebin. However, we did not observe signiﬁcant differences in
p38 MAP kinase and GSTa2 expression in cells exposed to 28 mM
()-cubebin compared to control cells (Fig. 5).
4. Discussion
The use of medicinal plants by the general population dates
back quite a long time and continues to be a common practice,
highlighting the importance of performing studies to assess their
genotoxicity (Teixeira et al., 2003). ()-Cubebin is a lignan of great
interest due to its trypanocidal (Bastos et al., 1999; Esperandim
et al., 2013; de Souza et al., 2005), analgesic, anti-inﬂammatory
(Bastos et al., 2001), leishmanicidal (Bodiwala et al., 2007) and
anti-proliferative activities (Yam et al., 2008). Due to the promising
therapeutic effects of ()-cubebin and considering the substantial
consumption of P. cubeba in some countries, we examined a
number of factors related to its safe consumption. The R. norvegicus
hepatoma cells (HTC cells) used in this study are proﬁcient at
metabolizing xenobiotics. Thus, HTC cells represent an ideal model
system for use in toxicity studies because they mimic the role of
the liver in metabolizing xenobiotics, primarily from food sources
in humans.
Published reports on the mutagenicity of ()-cubebin are
scarce. Maistro et al. (2011) observed a clastogenic effect in murine
bone marrow cells treated with 500 mg/kg and 2000 mg/kg ()-
cubebin. In the same study, no genotoxic effect was observed in the
peripheral blood cells of mice treated with 250 mg/kg ()-cubebinfor 24 h and at concentrations of 500 mg/kg and 2000 mg/kg for
4 h.
The mutagenicity and recombinogenicity effects of ()-cubebin
alone or in combination with doxorubicin were investigated in
Drosophila melanogaster by de Rezende et al. (2011). These authors
found that treatment with 0.25, 0.5 or 1.0 mM ()-cubebin
reduced the DNA damage induced by 0.2 mM doxorubicin.
However, administration of doxorubicin in combination with
2 mM ()-cubebin signiﬁcantly increased DNA damage, suggest-
ing that this lignan can positively or negatively inﬂuence
doxorubicin-induced mutagenicity, depending on the concentra-
tion applied (de Rezende et al., 2011).
In addition to the work performed examining ()-cubebin
directly, some researchers have studied plant extracts containing
()-cubebin (Junqueira et al., 2007; Medola et al., 2007; Resende
et al., 2010). In a study by Junqueira et al. (2007), mice treated with
seed extracts from P. cubeba at concentrations of 1.0 g/kg and 1.5 g/
kg for 48 and 72 h were examined for clastogenicity. This analysis
demonstrated a signiﬁcant increase in micronucleated polychro-
matic erythrocytes in the blood when compared with a control
group. Similarly, treatment with these concentrations of the seed
extract for 24 h signiﬁcantly increased the number of micronuclei
in mouse bone marrow cells. Our data suggest that ()-cubebin is
not the component of P. cubeba seeds that is responsible for the
genotoxicity observed in vivo. The concentration of the compound
used and the exposure time could also contribute to the variance
observed between these studies.
In addition to performing morphological analyses, we evaluated
whether treatment with 28 mM ()-cubebin alters the expression
of genes involved in cell signaling (p38 MAP kinase) and the
metabolism of xenobiotics (GSTa2). MAP kinases are key members
of a signaling pathway that plays a role in response to a variety of
extracellular stimuli (Zarubin and Han, 2005). The MAP kinase
family has been divided into the following four distinct subgroups:
(1) ERKs, which are kinases that are regulated by extracellular
stimuli; (2) JNK/SAPKA-c-Jun N-terminal kinase, which is activated
by stress; (3) BMK1-ERK5/large MAP kinase 1; and (4) the protein
kinase p38 group (Ono and Han, 2000). The p38 kinases have been
shown to be involved in inﬂammation, cell growth, differentiation,
cell cycle regulation and cell death (New and Han, 1998). The
glutathione S-transferases (GSTs) are members of a multigene family
involved in the detoxiﬁcation and, in some cases, activation of a
wide variety of chemicals (Eaton and Bammler, 1999). GST proteins
are the major detoxifying enzymes involved in phase II detoxiﬁca-
tion and are primarily found in the cytosol (Sheehan et al., 2001).
We found that the exposure of HTC cells to 28 mM ()-cubebin for
24 h did not result in an alteration of the expression of p38 MAP
kinase, suggesting that ()-cubebin does not induce any signiﬁcant
cellular changes. This ﬁnding conﬁrms the results obtained in the
cytotoxicity and proliferation assays, in which 28 mM ()-cubebin
was not found to be cytotoxic and did not affect cell growth.
Additionally, HTC cells exposed to 28 mM ()-cubebin for 24 h did
not show altered expression of GSTa2, suggesting that ()-cubebin
is not metabolized via this pathway. The gene expression data
further imply that ()-cubebin is safe and does not alter important
cellular events.
5. Conclusion
Our data suggest that ()-cubebin, which is obtained from P.
cubeba, should be consumed with caution, as the highest
concentration tested (280 mM) was found to be cytotoxic. The
other three concentrations used here (0.28 mM, 2.8 mM and
28 mM) were not mutagenic, and the results of these treatments
provide insight into the safe use of this lignan. Consistent with this
ﬁnding and in support of ()-cubebin’s therapeutic potential,
A.M. Niwa et al. / Journal of Food Composition and Analysis 30 (2013) 1–5 5()-cubebin does not affect the proliferation of rat liver tumor
cells. Finally, HTC cells exposed to 28 mM ()-cubebin for 24 h did
not show altered expression of p38 MAP kinase and GSTa2, again
indicating that ()-cubebin can be consumed safely, as it does not
alter important cellular pathways.
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